Toronto Dominion Bank
STOK icon

Toronto Dominion Bank’s Stoke Therapeutics STOK Stock Holding History

Toronto Dominion Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Hold
3,173,258
– – 0.12% 158
2026
Q1 		$103M Hold
3,173,258
– – 0.15% 126
2025
Q4 		$101M Hold
3,173,258
– – 0.15% 137
2025
Q3 		$74.6M Hold
3,173,258
– – 0.12% 164
2025
Q2 		$36M Hold
3,173,258
– – 0.06% 260
2025
Q1 		$21.1M Hold
3,173,258
– – 0.04% 317
2024
Q4 		$35M Buy
+3,173,258
New +$39M 0.06% 237

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Toronto Dominion Bank's STOK Position: Q2 2026 in Review

Toronto Dominion Bank held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 3,173,258 shares worth $104M. The position accounts for 0.12% of the portfolio, ranked #158.

Toronto Dominion Bank first reported a position in STOK in Q4 2024 and has held it in 7 quarters since. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Toronto Dominion Bank held 3,173,258 shares of Stoke Therapeutics worth $104M as of Q2 2026.
  • Toronto Dominion Bank left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up 0.12% of Toronto Dominion Bank's portfolio in Q2 2026, its #158 holding.
  • Toronto Dominion Bank first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.